Drug intelligence / Profile preview

Galli Eo

Development stage
Unknown
Lead developer
IRE ELiT
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Not Applicable
01

Overview

Galli Eo is a Germanium-68/Gallium-68 (68Ge/68Ga) generator system developed by IRE ELiT and distributed in Canada by Isologic Innovative Radiopharmaceuticals. It functions as a radiopharmacy device that elutes sterile gallium chloride (68Ga) solution, which is produced through the radioactive decay of its parent isotope, Germanium-68. This eluate is used for the in vitro radiolabeling of various radiopharmaceutical ligands, which are then utilized as tracers in positron emission tomography (PET) imaging, particularly in oncology applications. The system is designed as a closed, self-shielded unit, providing a reliable on-site source of the short-lived Gallium-68 radionuclide for diagnostic procedures in nuclear medicine. It received a Notice of Compliance from Health Canada in December 2019.

Brand names
Galli Eo
Other names
Galli Eo Ga-68 generatorGermanium-68/Gallium-68 generator68Ge/68Ga generator

Beyond the preview

Go deeper on Galli Eo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galli Eo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call